Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06376045 · ClinicalTrials.gov registry record · Phase 2
A Phase 2, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe Asthma
A Phase 2 study of Asthma, sponsored by Amgen.
- Active
- Registry status
- Phase 2
- Development phase
- 317
- Enrollment target
- 20
- Study locations
NCT06376045: Active Phase 2 study of Asthma, sponsored by Amgen.
NCT06376045 is a Phase 2 study of Asthma that is active but no longer recruiting, run by Amgen. The registered enrollment target is 317 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (80% lower). The trial reports 20 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06376045, a Phase 2 study of Asthma, is active but no longer recruiting, sponsored by Amgen.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 2
- Development phase
- 317 participants
- Enrollment target
- 20
- Study locations
Study Summary
The primary objective of this study is to describe the efficacy of rocatinlimab in reducing asthma exacerbations.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Rocatinlimab
Study Locations (20)
California
- Kern Research Inc - Bakersfield
- Orso Health Inc - La Jolla
- Imax Clinical Trials - La Palma
- Antelope Valley Clinical Trials - Lancaster
- Downtown Los Angeles Research Center, Inc - Los Angeles
- NewportNativeMD, Inc - Newport Beach
- University of California Irvine - Orange
- Apex Clinical Research - San Diego
- Allergy and Asthma Clinical Research - Walnut Creek
- Allianz Research Institute Westminster - Westminster
Florida
- St Francis Medical Institute - Clearwater
- BioMed Research Institute - Miami
- Bright Research Center LLC - Miami
- Infinity Life Research Group - Tamarac
- Clinical Research Trials of Florida Inc - Tampa
Georgia
- AllerVie Clinical Research- Columbus - Columbus
Idaho
- Treasure Valley Medical Research - Boise
Illinois
- Sneeze, Wheeze, and Itch Associates, LLC - Normal
Kentucky
- Family Allergy and Asthma Research Institute - Louisville
Maryland
- Chesapeake Clinical Research Inc - White Marsh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 317 participants |
| Start Date | 2024-05-24 |
| Est. Completion | 2026-12-11 |
| Phase | Phase 2 |
What the registry record for NCT06376045 still lists
NCT06376045 is an interventional study that assigns participants to a tested intervention. The registered 317 participants enrollment target is mid-sized for trials with a published cap, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (80% lower).
The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT06376045 names 20 study sites across 7 states, led by California, Florida, Georgia.
Frequently Asked Questions
What is clinical trial NCT06376045 about?
NCT06376045 is a clinical study titled "A Phase 2, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe Asthma". The primary objective of this study is to describe the efficacy of rocatinlimab in reducing asthma exacerbations.
What is the current status of trial NCT06376045?
This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 317 participants. The study started on 2024-05-24. Estimated completion is 2026-12-11.
What conditions does trial NCT06376045 study?
This clinical trial studies the following conditions: Asthma.
What interventions are being tested in trial NCT06376045?
The interventions under investigation include: Placebo (DRUG), Rocatinlimab (DRUG).
Who is sponsoring clinical trial NCT06376045?
This trial is sponsored by Amgen, which has 558 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06376045 being conducted?
This trial has 20 study locations across California, Florida, Georgia, Idaho, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06376045's enrollment target sits among peer trials
317 118th of 374 higher than 256 of 374 other Asthma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Asthma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Escitalopram in Asthma Patients With Frequent Exacerbation
RECRUITING · Phase 2
-
Metformin IN Asthma for Overweight and Obese Individuals (MINA)
RECRUITING · Phase 2
-
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
RECRUITING · Phase 2
-
ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
RECRUITING · Phase 2
-
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
RECRUITING · Phase 2
-
Supplementing L-citrulline to Overweight Late Asthma oNset Phenotypes
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04594642 · 317 participants · Phase 1
A Study of AZD0486 in Subjects With B-Cell Non-Hodgkin Lymphoma
- NCT04977453 · 317 participants · Phase 1
GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors
- NCT05137054 · 317 participants · Phase 1
A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Patients With Multiple Myeloma That is Resistant to Current Standard of Care Treatments
- NCT05382754 · 317 participants · NA
Home Apnea Testing in CHildren Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI